Raloxifene prevents urinary calcium loss in late postmenopausal women

被引：0
作者：
Talbot, JR
Marino, A
Zanchetta, J
Martinez, G
Moran, M
Messina, OD
机构：
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S234 / S235
页数：2
相关论文
共 50 条
[21]   The importance of urinary calcium in postmenopausal women with osteoporotic fracture [J].
Ochoa-Hortal Rull, Miguel Angel ;
del Carmen Cano-Garcia, Mara ;
Arrabal-Martin, Miguel ;
Angel Arrabal-Polo, Miguel .
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (3-4) :E183-E186
[22]   Clinical efficacy of raloxifene in postmenopausal women [J].
Agnusdei, D .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 85 (01) :43-46
[23]   Risedronate prevents bone loss in early postmenopausal women. [J].
Ebeling, P ;
Roberts, A ;
D'Emden, M ;
Nicholson, G ;
Crusan, C ;
Wenderoth, D ;
Ethgen, D ;
Hooper, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 :S403-S403
[24]   Oral weekly ibandronate prevents bone loss in postmenopausal women [J].
Tankó, LB ;
Felsenberg, D ;
Czerwinski, E ;
Burdeska, A ;
Jonkanski, I ;
Hughes, C ;
Christiansen, C .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (02) :159-167
[25]   Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate [J].
R. A. Wermers ;
C. P. Recknor ;
F. Cosman ;
L. Xie ;
E. V. Glass ;
J. H. Krege .
Osteoporosis International, 2008, 19 :1055-1065
[26]   Tibolone: Prevention of bone loss in late postmenopausal women [J].
Bjarnason, NH ;
Bjarnason, K ;
Haarbo, J ;
Rosenquist, C ;
Christiansen, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (07) :2419-2422
[27]   Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism [J].
Rubin, MR ;
Lee, KH ;
McMahon, DJ ;
Silverberg, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1174-1178
[28]   Calcium absorption during weight loss in postmenopausal women [J].
Cifuentes, M ;
Riedt, C ;
Chowdhury, H ;
Field, MP ;
Sherrell, RM ;
Shapses, SA .
FASEB JOURNAL, 2002, 16 (04) :A224-A225
[29]   Lasofoxifene is superior to raloxifene in the prevention of bone loss in postmenopausal women: 1 year results [J].
Bolognese, M ;
Moffett, A ;
Lee, A ;
Wolter, K ;
Day, W ;
Soniayaji, V ;
Gordon, P .
BONE, 2003, 32 (05) :S93-S93
[30]   Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate [J].
Wermers, R. A. ;
Recknor, C. P. ;
Cosman, F. ;
Xie, L. ;
Glass, E. V. ;
Krege, J. H. .
OSTEOPOROSIS INTERNATIONAL, 2008, 19 (07) :1055-1065
12345